Millie
your market intelligence analyst
Search Results
109 results
Your search is now limited to «FDA Actions» expert search.
Editorial Director of the Wellness Division, Fennell has 16 years’ experience specializing in diabetes and related health conditions.
More from Diabetes Self-Management - blog:
Healio News 10/03/2019 13:17
... P. Pai, PharmD , an associate professor of clinical pharmacy and deputy director of the pharmacokinetics core at the University of Michigan, and colleagues analyzed findings from the phase 3 OASIS and OPTIC studies, which the FDA based its approvals on, to assess the safety and efficacy of omadacycline in patients with diabetes.
More from Healio News:
FDLI SmartBrief 10/01/2019 12:36
Janssen's Invokana, or canagliflozin, gained FDA approval for a new indication covering use of the drug to decrease the risk of declining kidney function, end-stage kidney disease, heart failure hospitalization and cardiovascular death in adult patients with type 2 diabetes who ...
More from FDLI SmartBrief:
PMLiVE 10/01/2019 05:53
Based on the results of the CREDENCE trial, Invokana (canagliflozin) has become the only drug in the SGLT2 inhibitor class to be approved for treating diabetic kidney disease (DKD), and to reduce the risk of hospitalisation for heart failure in patients with type 2 diabetes and DKD.
More from PMLiVE:
Drugs.com 09/30/2019 16:09
In the United States, one in three people with T2D has DKD,1 which multiplies the risk of cardiovascular complications including heart failure and CV death, and puts patients on a trajectory to dialysis and kidney transplant.1,2 Additionally, heart failure is one of ...
More from Drugs.com:
PR Newswire 09/30/2019 09:47
FDA Approves New Drug to Treat Diabetes-Related Kidney Disease.
More from PR Newswire:
Endocrine News 09/25/2019 12:02
The FDA’s approval is based on positive results from three Phase 3 clinical trials evaluating the efficacy, safety, and utility of GVOKE in treating severe hypoglycemia when compared with conventional glucagon emergency kits among adults and children with ...
More from Endocrine News:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications